Anthropic’s Cowork brings Claude Code–style AI agents to the desktop, letting Claude access and manage local files and browse ...
CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...
Deep dive into RBAC vs ReBAC for enterprise sso. Learn which authorization model fits your ciam strategy and how to avoid role explosion in complex apps.
Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...
Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
MIT’s Recursive Language Models rethink AI memory by treating documents like searchable environments, enabling models to ...
The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...
Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
Federal officials say a company that operates hundreds of landing pages for AI answers is running an operation that has duped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback